Using Gene Knockout and Transgenic Approaches to Evaluate in vivo Functions of CNS Regeneration Inhibitors: How Important is Nogo ? David Mann Tammy Hibler.

Slides:



Advertisements
Similar presentations
Axonal Growth in the Adult Mammalian Nervous System: Regeneration and
Advertisements

Growth, Development and
Microglia are tissue-resident macrophages in the CNS.
80.3  The expression of mRNA for neurotrophins, and of their receptors is differentially upregulated after nerve injury  A strong role for BNDF, and.
Sara Herrera Advisor: Shubhik K. DebBurman Department of Biology Lake Forest College New  -Synuclein Mutants: How Do They Contribute To Parkinson’s Disease?
Investigation of mutated Cu/Zn Superoxide Dismutase Sam Schuberg Beckman Laboratory Howard Hughes Medical Institute: Summer 2007.
Myelin Components Central and peripheral myelin also contain myelin basic proteins. Seven related proteins produced from a single gene by alternative splicing.
Introduction to Neurotrophin Include: –Nerve Growth Factor (NGF) –Brain-Derived Neurotrophic Factor (BDNF) –Neurotrophin T-3 and NT-4 Receptors: –Low Affinity:
AMPAKINE Compounds for the Treatment of Rett Syndrome
THE NERVOUS SYSTEM. Brain WHAT PARTS DO YOU KNOW THAT ARE IN THE NERVOUS SYSTEM? Spinal Cord Peripheral Nerves.
Changes in Tumor Growth and Metastatic Capacities of J82 Human Bladder Cancer Cells Suppressed by Down-regulation of Calreticulin Expression Speaker: Yi-Chien.
For future. cAMP / PKA more on actin cytoskeleton and collapse! oncomodulin polyamines include prostheses go through Nogo etc more quickly maybe a bit.
NEUROINFLAMMATION GENERATION OF NEURAL SPECIFIC KNOCKOUT Generalized and neural restricted peroxisomal MFP2 deficiency causes demyelination and motoric.
Superoxide Dismutase and Amyotrophic Lateral Sclerosis
In vivo and in vitro zebrafish models for CNS axonal regeneration after injury Abdiel Badillo Jeffery A. Plunkett, Ph.D.
2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt All about the Neuron The.
The Nervous System. iction/drugs/mouse.html.
The role of of SynCAM2a in synapse formation Sofia Nakhnikian-Weintraub, Smith College 2012 Mentor: Courtney Easley-Neal, PI: Phil Washbourne.
Genetic enhancement of learning and memory in mice. Tang YP et al.
第三章 Survivin siRNA nano particles are capable of inhibiting liver cancer cell growth both in vitro and in vivo Suoqin Tang,MD, Kuiyao Qu,MD, Yi Zhang,MD.
Advisor: Shubhik K. DebBurman Department of Biology
Neuroglia and Myelin Dr. Raymond Colello
ORL1 inhibits axon regeneration.
Ms. Scribner’s Biology class
Takashi Tanaka, Michelle A. Soriano, Michael J. Grusby  Immunity 
David Mann Tammy Hibler Isaac Holmes Arun George Paul
Volume 38, Issue 2, Pages (April 2003)
D.W Huang, L McKerracher, P.E Braun, S David  Neuron 
Volume 21, Issue 2, Pages (February 2013)
Volume 45, Issue 3, Pages (February 2005)
Lack of Enhanced Spinal Regeneration in Nogo-Deficient Mice
Volume 18, Issue 12, Pages (December 2010)
Molecular Therapy - Methods & Clinical Development
Fig. 1. Aberrant JNK pathway activation in mouse models of ALS and in spinal cord tissue from patients with sporadic ALS. Aberrant JNK pathway activation.
Katerina Akassoglou, Wei-Ming Yu, Pinar Akpinar, Sidney Strickland 
Lost in the jungle: new hurdles for optic nerve axon regeneration
Volume 24, Issue 5, Pages (May 2016)
Volume 24, Issue 5, Pages (May 2016)
Volume 54, Issue 2, Pages (April 2007)
Volume 21, Issue 1, Pages (July 1998)
Volume 18, Issue 11, Pages (March 2017)
Immune Proteins in Brain Development and Synaptic Plasticity
Molecular Therapy - Methods & Clinical Development
Volume 18, Issue 4, Pages (April 2010)
Synaptic Innervation Density Is Regulated by Neuron-Derived BDNF
Subregion- and Cell Type–Restricted Gene Knockout in Mouse Brain
Volume 44, Issue 4, Pages (November 2004)
Volume 20, Issue 2, Pages (February 1998)
Fig. 4. Acute lung injury in miR-223−/y mice.
FARP1 Promotes the Dendritic Growth of Spinal Motor Neuron Subtypes through Transmembrane Semaphorin6A and PlexinA4 Signaling  BinQuan Zhuang, YouRong.
Evidence for an Age-Dependent Decline in Axon Regeneration in the Adult Mammalian Central Nervous System  Cédric G. Geoffroy, Brett J. Hilton, Wolfram.
Neuronal ATM level is reduced in mouse models of AD
Volume 10, Issue 5, Pages (May 2006)
Volume 11, Issue 6, Pages (December 2018)
miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
Fig. 9. Loss of the cholinergic receptor subunit Chrna6 does not alter the development and organization of the mdDA system.(A) In situ hybridization experiments.
Volume 127, Issue 4, Pages (November 2006)
Squeezing Axons Out of the Gray Matter
Reduced OXPHOS expression and increased UCP expression.
OTX2 in RMS and V-SVZ is non-cell-autonomous.
TRAF6 enhances I/R-induced oxidative stress.
Gli3 expression is reduced in the forebrain of Pdn/Pdn mutants.
A tph2 promoter fragment labels DR serotonergic neurons.
by Gonghua Huang, Yanyan Wang, Peter Vogel, and Hongbo Chi
Fig. 4. HERV-K env expression and injury to lower motor neurons.
Fig. 3. HERV-K–induced neuronal toxicity in vivo.
Volume 45, Issue 3, Pages (February 2005)
Chen Wu, Michelle E. Watts, Lee L. Rubin  Cell Reports 
Molecular Therapy - Methods & Clinical Development
Volume 18, Issue 6, Pages (June 2010)
Presentation transcript:

Using Gene Knockout and Transgenic Approaches to Evaluate in vivo Functions of CNS Regeneration Inhibitors: How Important is Nogo ? David Mann Tammy Hibler Isaac Holmes Arun George Paul

Road Map Background Background Hypotheses Hypotheses Specific Aims Specific Aims Expected Results Expected Results Conclusion Conclusion Future Research Future Research

The Big Picture Alzheimer’s Disease Alzheimer’s Disease Parkinson’s Disease Parkinson’s Disease Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Amyotrophic Lateral Sclerosis (Lou Gehrig’s Disease) Huntington’s Disease Huntington’s Disease Background

Spinal Cord Injury Cervical (C1-8) Thoracic (T1-12) Lumbar (L1-5) Sacral (S1-5) Coccygeal (C1) SCI on CST Purves, Dale et.al. Neuroscience. Sinauer Associates, Inc p14. Background

What are the myelin-derived inhibitors? MAG OMgp NgR Receptor 66 Amino Acid Domain Nogo-B Nogo-A Nogo-C CNS Neuron Fournier et. al. (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409: Background

Nogo Controversy BackgroundLabKnockoutMouse Extent of Regeneration Schwab Nogo-A - Modest Strittmatter Nogo-A/B -/- (6-11 weeks) Significant Strittmatter Nogo-A/B -/- (>11 weeks) None Hypothesis 2 Hypothesis 1

Our Hypotheses Hypothesis 1: Modest axonal regeneration in Schwab’s Nogo-A - mice was due to the presence of Nogo-B Hypothesis 1: Modest axonal regeneration in Schwab’s Nogo-A - mice was due to the presence of Nogo-B Hypothesis 2: Absence of axonal regeneration in older mice was due to increased age-dependant inhibition by OMgp Hypothesis 2: Absence of axonal regeneration in older mice was due to increased age-dependant inhibition by OMgp

Specific Aims Nogo-B Schwab Nogo-A/B -/- Mice WT OMgp (Young vs. Adult) Nogo-A/Nogo-B -/- -OMgp - OMgp ++ Hypothesis 2 Hypothesis 1 Aim 1 Aim 2 Aim 3 Aim 4

Aim 1: Aim 1: To study inhibitory effects of Nogo-B on axonal regeneration in Nogo-A - Mice Rationale: The presence of Nogo-B should account for the modest axonal regeneration in Schwab’s Nogo- A- mouse What we propose: Increased Axonal Regeneration Nogo-B Schwab’s Nogo-A - mouse Aim

Creation of the Nogo-A/B -/- Knockout Mouse using a Gene trapping vector A/B A A A/B/C Nogo Gene Exon 1 Nogo-B IRES-ß-geoPKG-NEO Gene Construct Schwab Aim

Has Nogo-B really been knocked out? In vitro test 1: Northern Blot WT Nogo-B mRNA Nogo-A -  -actin Negative Control Nogo-A/B -/- Expected Result

Has Nogo-B really been knocked out? In vitro test 2: Western Blot Nogo-B protein WTNogo-A - MAG protein Negative Control Nogo- A/B -/- Expected Result

Is the absence of Nogo-B affecting the general brain structure? In vivo test: Histological Analysis Nogo- A/B -/- Cerebral Cortex Hematoxylin & Eosin Staining Wild Type X-gal Staining Cerebellum Corpus Callosum Expected Result Nogo- A/B -/-

How does the absence of Nogo-B affect axonal growth? In vitro Neurite Outgrowth Assay Growth Cone Assay Control Nogo-A - Nogo-A/B -/- Expected Result

Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2

How does the absence of Nogo-B affect axonal regeneration after SCI? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Control Nogo-A - Nogo-A/B -/- Expected Result CST

How does the absence of Nogo-B affect axonal regeneration after SCI? In vivo Wild Type Nogo-A - Nogo- A/B -/- Sagittal Studies: Expected Result SCI CST

How does the absence of Nogo-B affect functional recovery after SCI? Nogo-A - Nogo-A/B -/- Behavioral Study: Expected Result Days Post SCI BBB Score

What we expect… More Axonal Regeneration Nogo-B Schwab Nogo-A - mice Expected Result

Aim 2: To study the expression of OMgp in wild-type mice: young (6-11 weeks) vs. adult (>11 weeks) What we propose (6-11 weeks) Younger Mice (6-11 weeks) (>11 weeks) Adult Mice (>11 weeks) Low OMgp Expression Increased OMgp Expression Rationale: OMgp expression should increase with age to account for age-dependant inhibition seen in Strittmatter’s Nogo-A/B -/- mice Aim

Does OMgp expression increase in adult mice? In vitro test 1: Northern Blot OMgp mRNA ß-actin mRNA Week 6 Week 11 Week 14 Expected Result

Does OMgp expression increase in adult mice? In vitro test 2: Western Blot Week 6 Week 11 Week 14 OMgp Protein MBP Expected Result

Does OMgp expression increase in adult mice? In vitro test 3: Immunohistochemistry Cerebellum Cerebral Cortex Lung Spinal Cord 6 weeks11 weeks14 weeks Expected Result

Does OMgp expression increase in adult mice? In vitro test 4: In Situ Hybridization Cerebellum 6 weeks Cerebral Cortex Lung 11 weeks14 weeks Spinal Cord Expected Result

What we expect… (6-11 weeks) Young Mice (6-11 weeks) (>11 weeks) Adult Mice (>11 weeks) Low OMgp ExpressionIncreased OMgp Expression Expected Result

Aim 3: Part 1: To study the inhibition by OMgp in wild-type mice: young (6-11 weeks) vs. adult (>11 weeks) What we propose Younger OMgp -/- Mice (6-11 weeks) Adult OMgp -/- Mice (>11 weeks) No Axonal Regeneration Axonal Regeneration Rationale: If OMgp is an inhibitor in adult mice, then absence of OMgp in adult mice will lead to axonal regeneration in adult OMgp -/- Mice Aim

Creation of the OMgp -/- Knockout Mouse Wild Type OMgp -/- Aim

Has OMgp really been knocked out? In vitro Northern Blot Northern Blot Western Blot Western Blot Histological Analysis Histological Analysis Expected Result Is the absence of OMgp affecting motor functions? Rotarod Test Rotarod Test

How does the absence of OMgp affect axonal growth? In vitro Neurite Out- growth Assay Growth Cone Assay OMgp -/- OMgp -/- Control OMgp -/- OMgp -/- (11-14 weeks) (6-11 weeks) Expected Result

Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2

How does the absence of OMgp affect axonal regeneration? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Wild Type OMgp -/- OMgp -/- (Adult) OMgp -/- OMgp -/- (Young) Expected Result CST

How does OMgp inhibition affect axonal regeneration? In vivo Wild Type OMgp -/- OMgp -/- (Adult) OMgp -/- OMgp -/- (Young) Sagittal Studies: Expected Result SCI CST

What we expect… Young OMgp -/- Mice (6-11 weeks) Adult OMgp -/- Mice (>11 weeks) No Axonal Regeneration Axonal Regeneration Expected Result

Part 2: To study the inhibition of OMgp in Nogo-A/B -/- mice: young (6-11 weeks) vs adult (>11 weeks) Aim 3: Young Nogo-A/B -/- -OMgp - Mice (6-11 weeks) Adult Nogo-A/B -/- -OMgp - Mice (>11 weeks) What we propose Excessive Axonal Regeneration Rationale: If OMgp is an inhibitor in older mice, then the absence of OMgp in young and adult Nogo-A/B -/- mice will have axonal regeneration after SCI Aim

Creation of the Nogo-A/B/OMgp -/-/- Knockout Mouse Wild Type Nogo-A/B -/- - OMgp - Aim

Has OMgp really been knocked out? In vitro Northern Blot Northern Blot Western Blot Western Blot Histological Analysis Histological Analysis Expected Result Is the absence of OMgp affecting motor functions? Rotarod Test Rotarod Test

How does the absence of Nogo-B affect axonal growth in Nogo-A/B -/- mice ? In vitro Nogo-A/B -/- Nogo-A/B -/- OMgp - OMgp - Control Nogo-A/B -/- Nogo-A/B -/- OMgp - (Adult) OMgp - (Younger) Neurite Out- growth Assay Growth Cone Assay Expected Result

Where & what are we looking for? In vivo Aim Dorsal Ventral Ipsi- Lateral Ventral Ipsi- Lateral ? ? ? ? T6 Dorsal Contra- Lateral Dorsal Contra- Lateral Rostral Caudal T4 L2

How does the absence of Nogo-B affect axonal regeneration in Nogo-A/B -/- mice ? In vivo Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Nogo-A/B -/- -OMgp - Wild Type YoungAdult Expected Result CST

How does the absence of Nogo-B affect axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type Nogo-A/B -/- -OMgp - (Adult) Nogo-A/B -/- -OMgp - (Young) Sagittal Studies: Expected Result SCI CST

What we expect… Young Nogo-A/B -/- -OMgp - Mice (6-11 weeks) Adult Nogo-A/B -/- -OMgp - Mice (>11 weeks) Excessive Axonal Regeneration Expected Result

Aim 4: To study the effects of the overexpression of OMgp in axonal regeneration after SCI in Nogo-A/B -/- mice Rationale: Since older mice highly express OMgp and do not display axonal regeneration, then young Nogo-A/B -/- mice will not display axonal regeneration when overexpressing OMgp. Aim Young Nogo-A/B -/- No Axonal Regeneration Overexpress OMgp What we propose:

Creation of Transgenic Nogo-A/B -/- with overexpression of OMgp MBP Promoter OMgp gene P-MBP OMgp gene OMgp ++ -Nogo-A/B -/- Aim

Has OMgp really been overexpressed in the Transgenic Nogo-A/B -/- mice? Western Blot OMgp MAG MBP Expected Result WT OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/-

How does OMgp overexpression affects axonal growth in Nogo-A/B -/- mice ? In vitro tests Control OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/- Neurite Outgrowth Growth Cone Collapse Expected Result

How does OMgp overexpression affects axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type OMgp + - Nogo-A/B -/- OMgp ++ -Nogo-A/B -/- Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Dorsal Ventral Coronal Sections at T4 (Rostral) Coronal Sections at L2 (Caudal) Coronal Studies: Expected Result

How does OMgp overexpression affects axonal regeneration in Nogo-A/B -/- mice ? In vivo Wild Type OMgp + - Nogo- A/B -/- OMgp ++ - Nogo- A/B -/- Sagittal Studies: Expected Result SCI CST

How does OMgp overexpression affect axonal regeneration in Nogo-A/B -/- mice ? In vivo OMgp + -Nogo-A/B -/- OMgp ++ -Nogo-A/B -/ Days Post SCI BBB Score Behavioral Study Expected Result

What we expect… Nogo-A/B -/- No Axonal Regeneration Overexpresses OMgp Expected Result

Conclusion Nogo-B Aim 1 Aim 2 Aim 3 Aim 4 Schwab Nogo-A - Mice WT OMgp Nogo-A/Nogo-B -/- -OMgp - OMgp ++ - Nogo-A/B -/- Nogo-B is a secondary inhibitor OMgp is an inhibitor in adult mice

Future Research Possible drugs that can inhibit Nogo, OMgp and MAG Possible drugs that can inhibit Nogo, OMgp and MAG Directed pathways for axonal regeneration Directed pathways for axonal regeneration

Acknowledgements Dr. Shubhik DebBurman Dr. Shubhik DebBurman Nijee Sharma Nijee Sharma D’Anne Duncan D’Anne Duncan